BFAM
Bright Horizons Family Solutions Inc.
BFAM has slightly lower modeled downside risk, despite its lower overall score.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over BFAM overall, supported by stronger fundamentals and stronger modeled upside.
BFAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
BFAM's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BFAM PE Valuation
BFAM has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
BFAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BFAM's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over BFAM on the outlook, with more favorable revenue expectations.
BFAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.47 | — |
| Q3 2026 | -$2.97 | -185% |
| Q2 2026 | $3.16 | +3.6% |
| Q1 2026 | $3.32 | +20% |
| Q4 2025 | $3.36 | +40% |
| Q3 2025 | $3.48 | +74% |
| Q2 2025 | $3.05 | +74% |
| Q1 2025 | $2.77 | +94% |
| Q4 2024 | $2.40 | +88% |
BFAM has swung to a loss: it lost $2.97 per share over the past year, after a profit the year before.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over BFAM on earnings, with more consistent year-over-year improvement.
BFAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $841.5M | +4.8% |
| Q2 2026 | $779.2M | +6.5% |
| Q1 2026 | $712.2M | +7% |
| Q4 2025 | $733.7M | +8.8% |
| Q3 2025 | $802.8M | +12% |
| Q2 2025 | $731.6M | +9.2% |
| Q1 2025 | $665.5M | +6.9% |
| Q4 2024 | $674.1M | +9.5% |
BFAM's revenue has grown year over year for 22 quarters in a row: $841M last quarter, up 4.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -37 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 9.1% | -0.2 points |
| Q4 2025 | 6.2% | -1 points |
| Q3 2025 | 15% | +2.6 points |
| Q2 2025 | 12% | +1.4 points |
| Q1 2025 | 9.4% | +2.9 points |
| Q4 2024 | 7.2% | +2.6 points |
BFAM has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
BFAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$25.1M | +$17.4M |
| Q2 2026 | $76.1M | -34% |
| Q1 2026 | $87.6M | +23% |
| Q4 2025 | $114.7M | +29% |
| Q3 2025 | -$42.4M | -$10.3M |
| Q2 2025 | $115.4M | +33% |
| Q1 2025 | $70.9M | -27% |
| Q4 2024 | $88.6M | +37% |
BFAM has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
BFAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.4% | -3.3M shares |
| 1 year | -16% | -9M shares |
| 3 years | -17% | -9.6M shares |
| 5 years | -20% | -11.9M shares |
| Available history | -18% | -10.5M shares |
BFAM has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $88M |
| Q2 2026 | $246.7M |
| Q1 2026 | $224.8M |
| Q4 2025 | $120.7M |
| Q3 2025 | $44.3M |
| Q2 2025 | $40.8M |
| Q1 2025 | $19.6M |
| Q4 2023 | — |
BFAM spent $680M buying back its own shares over the past year.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BFAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.5x | High |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
BFAM's net debt is about 9.5 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BFAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 7.9 | Oversold |
BFAM's weekly RSI is 30 (neutral) and its Stochastic is 8 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
BFAM PE vs Consumer Cyclical Sector
| Metric | BFAM | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 25% above |
| PE % | 6 | 47 | 41 pts below |
BFAM has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
BFAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.9 | 16% below |
| 20 week MA | $68.6 | 23% below |
| 50 week MA | $76.3 | 31% below |
| 100 week MA | $96.6 | 45% below |
| 200 week MA | $98.9 | 47% below |
BFAM is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
BFAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $150.9 | $165.3 | +9.6% |
| 2021 | $165.3 | $123.2 | -25% |
| 2022 | $123.2 | $59.9 | -51% |
| 2023 | $59.9 | $94.2 | +57% |
| 2024 | $94.2 | $110.5 | +17% |
| 2025 | $110.5 | $101.3 | -8.3% |
| 2026 YTD | $101.3 | $52.8 | -48% |
BFAM has finished lower in three of the last six years. It's down 48% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over BFAM on returns for 2026, with the stronger performance.